Picroside II protects against sepsis via suppressing inflammation in mice. 2016

Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
Jiangsu Province Key Laboratory of Anesthesiology and Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology, Xuzhou Medical UniversityXuzhou, China; Department of Anesthesiology and SICU, Xinhua Hospital, School of Medicine, Shanghai Jiaotong UniversityShanghai, China.

Picroside II, an iridoid compound extracted from Picrorhiza, exhibits anti-inflammatory and anti-apoptotic activities. We explored the protective effects and mechanisms of picroside II in a mouse model of sepsis induced by cecal ligation and puncture (CLP), using three groups of mice: Group A (sham), Group B (CLP+NS) and Group C (CLP+20 mg/kg picroside II). The mortality in mice with sepsis was decreased by the administration of picroside II, and lung injury was alleviated simultaneously. Picroside II treatment enhanced bacterial clearance in septic mice. Further, picroside II treatment alleviated the inflammatory response in sepsis and enhanced immune function by inhibiting the activation of NLRP3 inflammasome and NF-κB pathways. Picroside II may represent an anti-inflammatory drug candidate, providing novel insight into the treatment of sepsis.

UI MeSH Term Description Entries

Related Publications

Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
January 2015, International journal of clinical and experimental medicine,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
February 2015, European journal of pharmacology,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
June 2017, Inflammation,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
November 2021, Biochemical and biophysical research communications,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
September 2022, Cells,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
April 2015, Experimental and therapeutic medicine,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
February 2019, Reproductive sciences (Thousand Oaks, Calif.),
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
July 2015, Scientific reports,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
January 2024, Journal of inflammation research,
Ying Huang, and Miao Zhou, and Chengbao Li, and Yuanli Chen, and Wei Fang, and Guo Xu, and Xueyin Shi
January 2013, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!